UPC · Universe Pharmaceuticals INC
$5.03
-0.33 (-6.16%)
At close · Aug 25
Market Cap
$3.56M
Shares
663,915
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-31 | — | |
| 6-K | 2026-07-29 | 2026-03-31 | |
| 6-K | 2026-06-26 | — | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-04-16 | — | |
| 6-K | 2026-02-11 | — | |
| 20-F | 2026-01-29 | 2025-09-30 | |
| 6-K | 2025-09-03 | — | |
| 6-K | 2025-08-26 | — | |
| 6-K | 2025-07-29 | — | |
| 6-K | 2025-07-03 | — | |
| 20-F | 2025-04-29 | 2024-09-30 | |
| 6-K | 2025-03-20 | — | |
| 6-K | 2025-03-11 | — | |
| 6-K | 2025-03-03 | — | |
| 6-K | 2025-02-25 | — | |
| 6-K | 2025-02-20 | — | |
| 6-K | 2025-02-18 | — | |
| 6-K | 2025-02-11 | — | |
| 6-K | 2025-02-03 | — | |
| 6-K | 2025-01-30 | — | |
| 6-K | 2024-12-12 | — | |
| 6-K | 2024-11-13 | — | |
| 6-K | 2024-11-01 | — | |
| 6-K | 2024-10-10 | — | |
| 6-K | 2024-09-27 | — | |
| 6-K | 2024-09-20 | 2024-03-31 | |
| 6-K | 2024-09-03 | — | |
| 6-K | 2024-07-18 | — | |
| 6-K | 2024-02-07 | — | |
| 20-F | 2024-01-30 | 2023-09-30 | |
| 6-K | 2023-08-31 | 2023-03-31 | |
| 6-K | 2023-08-16 | — | |
| 6-K | 2023-08-04 | — | |
| 6-K | 2023-07-27 | — | |
| 6-K | 2023-07-05 | — | |
| 6-K | 2023-05-24 | — | |
| 6-K | 2023-05-05 | — | |
| 20-F | 2023-02-10 | 2022-09-30 | |
| 6-K | 2022-11-14 | — | |
| 6-K | 2022-09-28 | — | |
| 6-K | 2022-08-29 | — | |
| 6-K | 2022-08-16 | 2022-03-31 | |
| 6-K | 2022-07-19 | — | |
| 6-K | 2022-01-31 | — | |
| 20-F | 2022-01-31 | 2021-09-30 | |
| 6-K | 2021-12-15 | — | |
| 6-K | 2021-12-10 | — | |
| 6-K | 2021-12-09 | — | |
| 6-K | 2021-08-02 | — |
Showing 1–50 of 52 filings
Key facts
CIK
1809616
CUSIP
G9442G138
13F (30d)
4 filings
4 filers